CONMED ROE 2010-2024 | CNMD

Current and historical return on equity (ROE) values for CONMED (CNMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
CONMED ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.13B $0.93B 15.07%
2024-06-30 $0.10B $0.88B 11.76%
2024-03-31 $0.08B $0.86B 10.17%
2023-12-31 $0.07B $0.83B 8.22%
2023-09-30 $0.06B $0.80B 7.68%
2023-06-30 $0.09B $0.78B 11.89%
2023-03-31 $-0.09B $0.75B -12.89%
2022-12-31 $-0.08B $0.75B -10.94%
2022-09-30 $-0.08B $0.72B -11.20%
2022-06-30 $-0.11B $0.67B -15.18%
2022-03-31 $0.07B $0.79B 8.72%
2021-12-31 $0.06B $0.79B 8.24%
2021-09-30 $0.06B $0.76B 8.45%
2021-06-30 $0.05B $0.74B 7.55%
2021-03-31 $0.01B $0.73B 2.01%
2020-12-31 $0.01B $0.71B 1.44%
2020-09-30 $0.00B $0.68B 0.14%
2020-06-30 $0.00B $0.68B 0.14%
2020-03-31 $0.03B $0.70B 4.84%
2019-12-31 $0.03B $0.71B 4.14%
2019-09-30 $0.03B $0.70B 4.36%
2019-06-30 $0.03B $0.70B 4.29%
2019-03-31 $0.03B $0.69B 4.82%
2018-12-31 $0.04B $0.66B 6.45%
2018-09-30 $0.07B $0.65B 11.34%
2018-06-30 $0.07B $0.65B 11.78%
2018-03-31 $0.07B $0.64B 11.61%
2017-12-31 $0.06B $0.63B 9.25%
2017-09-30 $0.02B $0.59B 2.58%
2017-06-30 $0.02B $0.58B 2.58%
2017-03-31 $0.01B $0.58B 2.07%
2016-12-31 $0.02B $0.58B 2.58%
2016-09-30 $0.02B $0.58B 2.75%
2016-06-30 $0.02B $0.58B 3.10%
2016-03-31 $0.02B $0.58B 3.79%
2015-12-31 $0.03B $0.59B 5.19%
2015-09-30 $0.03B $0.58B 5.71%
2015-06-30 $0.03B $0.58B 4.47%
2015-03-31 $0.03B $0.57B 4.94%
2014-12-31 $0.03B $0.58B 5.40%
2014-09-30 $0.03B $0.59B 5.18%
2014-06-30 $0.04B $0.60B 5.85%
2014-03-31 $0.04B $0.60B 5.89%
2013-12-31 $0.04B $0.61B 6.05%
2013-09-30 $0.04B $0.59B 6.21%
2013-06-30 $0.04B $0.59B 6.69%
2013-03-31 $0.04B $0.60B 6.67%
2012-12-31 $0.04B $0.61B 6.70%
2012-09-30 $0.00B $0.60B 0.68%
2012-06-30 $0.00B $0.59B 0.51%
2012-03-31 $0.00B $0.59B 0.34%
2011-12-31 $0.00B $0.57B 0.17%
2011-09-30 $0.03B $0.61B 5.47%
2011-06-30 $0.03B $0.62B 5.70%
2011-03-31 $0.03B $0.60B 5.46%
2010-12-31 $0.03B $0.59B 5.15%
2010-09-30 $0.03B $0.58B 4.83%
2010-06-30 $0.02B $0.58B 3.46%
2010-03-31 $0.01B $0.58B 2.44%
2009-12-31 $0.01B $0.58B 1.94%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.216B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36